SGMO

Sangamo Therapeutics, Inc. is a clinical-stage biotechnology company developing genomic medicines. The company specializes in gene therapy and cell therapy using zinc finger protein technology for treating genetic diseases and cancer. Sangamo has partnerships with major pharmaceutical companies to advance its therapeutic programs.